Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.
Context. - Antibiotic use is associated with increased rates of antibiotic-resistant organisms.
A previous study has shown that colds, upper respiratory tract infections, and bronchitis account for nearly one third of all antibiotic prescribing by ambulatory care physicians.
How frequently antibiotics are prescribed for these conditions and for and by whom is not known.
- To measure antibiotic prescription rates and to identify predictors of antibiotic use for adults diagnosed as having colds, upper respiratory tract infections, and bronchitis in the United States.
- Sample survey of practicing physicians participating in the National Ambulatory Medical Care Survey, 1992.
- Office-based physician practices.
- Physicians (n=1529) completing patient record forms for adult office visits (n=28787).
Main Outcome Measures
- Antibiotic prescriptions for colds, upper respiratory tract infections, and bronchitis.
- Office visits for colds, upper respiratory tract infections, and bronchitis resulted in approximately 12 million antibiotic prescriptions, accounting for 21% of all antibiotic prescriptions to adults in 1992.
A total of 51% of patients diagnosed as having colds, 52% of patients diagnosed as having upper respiratory tract infections, and 66% of patients diagnosed as having bronchitis were treated with antibiotics.
Female sex (odds ratio [OR], 1.65 ; 95% confidence interval [Cl], 1. 05-2. (...)
Mots-clés Pascal : Bronchite, Rhume banal, Virose, Infection, Voie respiratoire supérieure, Antibiotique, Epidémiologie, Prescription médicale, Evaluation, Facteur prédictif, Médecin généraliste, Homme, Appareil respiratoire pathologie, Bronche pathologie, ORL pathologie, Chimiothérapie, Politique sanitaire, Economie santé
Mots-clés Pascal anglais : Bronchitis, Common cold, Viral disease, Infection, Upper respiratory tract, Antibiotic, Epidemiology, Medical prescription, Evaluation, Predictive factor, General practitioner, Human, Respiratory disease, Bronchus disease, ENT disease, Chemotherapy, Health policy, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0485176
Code Inist : 002B02S07. Création : 03/02/1998.